Part of the ERG Network of Research Sites
ERG’s mission is to provide the highest quality clinical trial execution across all clinical research phases to help sponsors speed lifesaving and life-enhancing therapeutics to market as quickly and safely as possible.
Ohio Clinical Trials
For more than 20 years, Ohio Clinical Trials has been a leader in clinical research, specializing in abuse potential assessments, pain management, central nervous system (CNS) research, and drug interaction studies. Our experienced clinical and pharmacy teams have extensive experience conducting studies involving oral, intravenous (IV), and intranasal investigational medications.
For over a decade, the site has also conducted specialized respiratory safety studies related to opioid medications, helping researchers better understand how these treatments affect the body. This depth of experience has made Ohio Clinical Trials a trusted partner for complex research requiring close medical oversight and monitoring.
Conditions We Research:
- Respiratory Depression
- Heart Health
- Healthy Volunteer
- Obesity
- Substance Use Disorders Psychedelics
- Type 2 Diabetes
Our Clinical Research Facilities
Columbus, OH Location
- 12,000 square feet
- 5+ private rooms for special populations (this includes surgical / post-op)
- 60+ beds
- Less than 1 mile from the nearest emergency room
- 5,000+ pre-identified overweight or obese subjects
- 3,200+ pre-identified subjects for HAP/HAL studies
- 2.1 million metropolitan area residents
- >90% Average historical retention rate for both Phase 1 and Phase 2-3 trials
- On-site processing laboratory, with a -70º C freezer and two -20º C freezers and a variable temperature freezer that can accommodate up to -80º C
- Computerized temperature/humidity monitoring system for selected rooms, freezers, and refrigerators, with programmed alerts
- Multiple monitor rooms
- Pharmacy cleanroom suite with Class 5 hood
- Telemetry capabilities
- Experienced pharmacy team in product preparation and administration including injectables (IV, IM, subcutaneous), over-encapsulation, and nasal insufflation